UNITED STATES |
SECURITIES AND EXCHANGE COMMISSION |
WASHINGTON, D.C. 20549 |
FORM 8-K |
CURRENT REPORT |
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Date of Report (Date of earliest event reported): October 19, 2016 |
SHIRE PLC |
(Exact name of registrant as specified in its charter) |
Jersey, Channel Islands | 0-29630 | 98-0601486 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
5 Riverwalk, Citywest Business Campus, Dublin 24,
Republic of Ireland |
Registrant’s telephone number, including area code: +353 1 429 7700 |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.): |
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events
Shire plc has issued the press release attached hereto as Exhibit 99.1 which is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits. The following exhibit is filed herewith:
99.1 Press Release dated October 19, 2016
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Shire plc | ||
By: | /s/ W R Mordan | |
Name: | Bill Mordan | |
Title: | Company Secretary |
Date: October 19, 2016
EXHIBIT INDEX
Exhibit No. |
Description | |
99.1 | Press Release dated October 19, 2016 |
Exhibit 99.1
Press Release www.shire.com
|
Shire to announce third quarter 2016 results
Dublin, Ireland – October 19, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG), will announce third quarter 2016 earnings on Tuesday November 1, 2016.
Results press release will be issued at: | 12:00 GMT / 08:00 EDT |
Investor conference call time: | 14:00 GMT / 10:00 EDT |
Live conference call for investors:
Flemming Ornskov, MD, Chief Executive Officer and Jeff Poulton, Chief Financial Officer will host the investor and analyst conference call at 10:00 EDT / 14:00 GMT.
The details of the conference call are as follows:
UK dial in: | 0808 237 0030 or 020 3139 4830 |
US dial in: | 1 866 928 7517 or 1 718 873 9077 |
International Access Numbers: | Click here |
Password/Conf ID: | 42020034# |
Live Webcast: | Click here |
Replay:
A replay of the presentation will be available for two weeks by phone and by webcast for three months. Replay information can be found on the Investor Relations section of Shire’s website at http://investors.shire.com/.
For further information please contact:
Investor Relations | ||
Sarah Elton-Farr | seltonfarr@shire.com | +44 1256 894157 |
Ian Karp | ikarp@shire.com | +1 781 482 9018 |
Robert Coates | rcoates@shire.com | +44 1256 894874 |
Notes to editors
About Shire
Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX